McDaniel Files Suit over Marketing of Anti-Psychotic Drug

LITTLE ROCK, AR - Arkansas Attorney General Dustin McDaniel is accusing drug companies of improperly marketing an anti-psychotic drug.  McDaniel asked a state judge today to force the firms to repay millions paid by the state's Medicaid program for unnecessary prescriptions.

McDaniel filed a lawsuit in Pulaski County Circuit Court against Janssen Pharmaceutica, Janssen, LP and Johnson and Johnson Incorporated.

In the filing, McDaniel says the companies "engaged in a direct, illegal, nationwide program of promotion of the use of Risperdal for non-medically necessary uses."

Johnson & Johnson is the parent company of both Janssen Pharmaceutica and Janssen, LP.

The lawsuit did not specify how much the state is seeking, but McDaniel has estimated that the state's Medicaid program spent about $200 million over eight years to pay for prescriptions for Zyprexa, Seroquel and Risperdal.  The lawsuit filed today focuses solely on Risperdal.

(Copyright 2007 by The Associated Press.  All Rights Reserved.)